Dr. Reddy's Laboratories Limited (DRREDDY) — Announcement Announcement

· NSE Neutral
📢 Key Event
Company schedules investor meeting with Bank of America
💡 Investor Takeaway
Shareholders can attend or benefit from direct management interaction during the meeting.

Dr. Reddy's Laboratories announced on June 1, 2026, that its management will attend a scheduled in-person investor meeting with Bank of America in Hyderabad on June 5, 2026, from 8:00 to 9:00 IST, as part of ongoing institutional engagement. The notice emphasizes regulatory compliance under SEBI's Listing Obligations and Disclosure Requirements and includes a disclaimer that the schedule may change due to exigencies. This event provides investors with a direct platform to engage with company leadership, potentially influencing market perception and liquidity around the stock.

📄 View Original Announcement (PDF)

About Dr. Reddy's Laboratories Limited (DRREDDY)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,11,568.6 Cr P/E: 20.0 ROE: 16.6% ROCE: 19.7%

View full DRREDDY stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.